Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.33
(1.09%)
CNY 8.33
(1.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 431.02 Million CNY | -3.82% |
| 2022 | 448.15 Million CNY | -10.61% |
| 2021 | 501.36 Million CNY | -11.1% |
| 2020 | 563.96 Million CNY | 13.22% |
| 2019 | 498.11 Million CNY | 41.93% |
| 2018 | 350.94 Million CNY | 97.55% |
| 2017 | 177.64 Million CNY | 8.21% |
| 2016 | 164.16 Million CNY | -2.49% |
| 2015 | 168.35 Million CNY | 2.57% |
| 2014 | 164.13 Million CNY | 39.06% |
| 2013 | 118.03 Million CNY | 10.82% |
| 2012 | 106.5 Million CNY | 38.4% |
| 2011 | 76.95 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 107.13 Million CNY | -7.33% |
| 2024 Q1 | 107.82 Million CNY | -21.97% |
| 2024 Q2 | 120.02 Million CNY | 11.31% |
| 2023 Q3 | 87.6 Million CNY | -19.93% |
| 2023 Q4 | 138.18 Million CNY | 57.73% |
| 2023 FY | 431.02 Million CNY | -3.82% |
| 2023 Q1 | 95.82 Million CNY | -16.84% |
| 2023 Q2 | 109.41 Million CNY | 14.19% |
| 2022 FY | 448.15 Million CNY | -10.61% |
| 2022 Q3 | 105.15 Million CNY | -5.98% |
| 2022 Q4 | 115.22 Million CNY | 9.57% |
| 2022 Q2 | 111.83 Million CNY | -3.54% |
| 2022 Q1 | 115.94 Million CNY | -1.36% |
| 2021 Q2 | 134.66 Million CNY | 6.09% |
| 2021 Q1 | 126.93 Million CNY | -35.3% |
| 2021 Q3 | 122.21 Million CNY | -9.24% |
| 2021 Q4 | 117.54 Million CNY | -3.82% |
| 2021 FY | 501.36 Million CNY | -11.1% |
| 2020 Q1 | 101.33 Million CNY | -24.81% |
| 2020 FY | 563.96 Million CNY | 13.22% |
| 2020 Q3 | 137.32 Million CNY | 6.37% |
| 2020 Q4 | 196.19 Million CNY | 42.86% |
| 2020 Q2 | 129.1 Million CNY | 27.4% |
| 2019 Q1 | 100.12 Million CNY | -1.44% |
| 2019 FY | 498.11 Million CNY | 41.93% |
| 2019 Q4 | 134.77 Million CNY | 12.18% |
| 2019 Q3 | 120.14 Million CNY | -16.02% |
| 2019 Q2 | 143.06 Million CNY | 42.89% |
| 2018 Q1 | 72 Million CNY | 15.57% |
| 2018 Q2 | 83.47 Million CNY | 15.94% |
| 2018 Q4 | 101.58 Million CNY | 8.22% |
| 2018 Q3 | 93.87 Million CNY | 12.45% |
| 2018 FY | 350.94 Million CNY | 97.55% |
| 2017 Q4 | 62.3 Million CNY | 48.3% |
| 2017 Q1 | 37.84 Million CNY | -28.77% |
| 2017 Q2 | 35.48 Million CNY | -6.23% |
| 2017 Q3 | 42.01 Million CNY | 18.39% |
| 2017 FY | 177.64 Million CNY | 8.21% |
| 2016 Q2 | 42.8 Million CNY | 6.84% |
| 2016 Q4 | 53.13 Million CNY | 88.61% |
| 2016 Q3 | 28.17 Million CNY | -34.19% |
| 2016 Q1 | 40.06 Million CNY | 0.0% |
| 2016 FY | 164.16 Million CNY | -2.49% |
| 2015 FY | 168.35 Million CNY | 2.57% |
| 2014 Q2 | 33.78 Million CNY | 0.0% |
| 2014 FY | 164.13 Million CNY | 39.06% |
| 2014 Q1 | 33.78 Million CNY | 0.0% |
| 2013 FY | 118.03 Million CNY | 10.82% |
| 2012 FY | 106.5 Million CNY | 38.4% |
| 2011 FY | 76.95 Million CNY | 0.0% |